Articles by Erin Slifka

Emergent BioSolutions plans to resume Covid-19 vaccine production at its Baltimore plant after getting the green light from the FDA.

Facebook posted sharp growth in quarterly revenue and profit, fueled by robust digital ad spending, as it continues to face scrutiny over the size and influence of its platforms.

Two of the bankrupt firearms manufacturer’s insurers are backing the offer of $3.66 million each for nine families, a person with knowledge of the case said.

The device maker posted the biggest spring-quarter profit in its 45-year history, leading a streak of record-setting earnings for technology companies even as the pandemic continues to weigh on the global economy.

Some companies report growth is slowing, adding to challenges as they deal with rising costs and supply constraints.

The region is seeing a travel boom, but supplying airports with jet fuel has become harder with a scarcity of truck drivers, limited space on pipelines and competing demand for fuel to fight wildfires.

The conglomerate raised its goal for cash flows and said its adjusted profit topped expectations, as it continues to recover from pandemic-induced shocks to the global economy.

Pharma executives, lobbyists and consultants are mobilizing to fight what has become a threat to drug companies’ bottom lines: an agreement to better harmonize corporate taxation around the globe.

The Silicon Valley electric-car company posted a record quarterly profit of $1.1 billion as it largely sidestepped the effects of a global chip shortage that has constricted production for many global auto makers.